Unlocked Access
FULL SUPPLEMENT: Acneceuticals maximized therapeutic outcomes in a real-world setting
June 2025 | Volume 24 | Issue 6 | Department | 08420s1 | Copyright © June 2025
In this issue:
Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris
Acne vulgaris is a common, ...
Read MoreINDIVIDUAL ARTICLE: Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris
June 2025 | Volume 24 | Issue 6 | Supplement Individual Articles | 08421s3 | Copyright © June 2025
Background: Acne vulgaris is a common, multifactorial inflammatory skin disease for which there are many pharmacologic and procedural interventions. Recent publications have stre...
Read MorePractical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection
June 2025 | Volume 24 | Issue 6 | Original Article | 621 | Copyright © June 2025
Acute exacerbations or flares are a key characteristic of atopic dermatitis (AD), often associated with sleep deprivation, as well as experiences of stigmatization, social withdrawal, anxiety, an...
Read MoreRapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis
June 2025 | Volume 24 | Issue 6 | Original Article | 600 | Copyright © June 2025
Background: In the ADORING 1 and 2 phase 3 trials, tapinarof cream 1% once daily (QD) demonstrated significant efficacy and was well tolerated in adults and children down to 2 ye...
Read MoreThiamidol: A Breakthrough Innovation in the Treatment of Hyperpigmentation
June 2025 | Volume 24 | Issue 6 | Original Article | 608 | Copyright © June 2025
Cutaneous hyperpigmentation, including melasma, solar lentigines, and post-inflammatory hyperpigmentation (PIH), results in a significant impact on patients’ quality of life. Unfortunately,...
Read MorePDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact
June 2025 | Volume 24 | Issue 6 | Original Article | 631 | Copyright © June 2025
Phosphodiesterase-4 (PDE4) inhibitors are reshaping the treatment landscape for chronic inflammatory skin diseases by offering effective, non-steroidal options for conditions like psoriasis, atop...
Read MoreExploring the Gut Microbiome's Role in Drug-Induced Photosensitivity: A Need for Deeper Investigation
June 2025 | Volume 24 | Issue 6 | Editorials | e40 | Copyright © June 2025
Social Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa
June 2025 | Volume 24 | Issue 6 | Editorials | e45 | Copyright © June 2025
Exploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report
June 2025 | Volume 24 | Issue 6 | Case Reports | 636 | Copyright © June 2025
Calcitonin gene-related peptide (CGRP) is a neuropeptide involved in neurogenic inflammation and vasodilation, playing a key role in the pathophysiology of both migraines and inflammatory skin co...
Read MoreConsiderations on Concurrent Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Isotretinoin
June 2025 | Volume 24 | Issue 6 | Editorials | 638 | Copyright © June 2025
Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study
June 2025 | Volume 24 | Issue 6 | Features | 639 | Copyright © June 2025
Isotretinoin is used to treat severe nodulocystic acne. Cumulative doses of 120 to 150 mg/kg have been shown to limit adverse events while maximizing efficacy. Also proven safe, doses of 220 mg/k...
Read MoreNeed for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares
June 2025 | Volume 24 | Issue 6 | Case Reports | 634 | Copyright © June 2025
Seborrheic dermatitis is a common chronic inflammatory skin condition historically treated with topical antifungals and anti-inflammatory agents. While topical corticosteroids are frequently used...
Read MoreFULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom 6): A Practical Algorithm Integrating Skincare for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
May 2025 | Volume 24 | Issue 5 | Department | 49630s1 | Copyright © May 2025
INDIVIDUAL ARTICLE: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
May 2025 | Volume 24 | Issue 5 | Supplement Individual Articles | 49631s3 | Copyright © May 2025
Introduction: Hormonal therapies, typically used in the treatment of breast and prostate cancer patients, have been associated with numerous skin toxicities that can impact quality...
Read MoreFULL SUPPLEMENT: Defining and Treating Pre-Aging With a Novel Multi-Functional Cosmetic Peptide, Acetyl Dipeptide-31 Amide
May 2025 | Volume 24 | Issue 5 | Department | 51180s1 | Copyright © May 2025
INDIVIDUAL ARTICLE: A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a Novel Cosmetic Peptide, Acetyl Dipeptide-31 Amide (AP31)
May 2025 | Volume 24 | Issue 5 | Supplement Individual Articles | 51181s4 | Copyright © May 2025
Background: Patients experiencing signs of pre-aging in their 20s and early 30s desire solutions including topical skincare and cosmetic procedures to help preserve skin quality an...
Read MoreRandomized-Controlled Trial Comparing Safety and Efficacy of Repairing Balm vs Topical Antimicrobial for Post-Procedural Wounds
May 2025 | Volume 24 | Issue 5 | Original Article | 507 | Copyright © May 2025
Background: Actinic keratoses (AK) are pre-cancerous, intraepidermal lesions that exist on a continuum with squamous cell carcinoma. Cryotherapy using liquid nitrogen freezi...
Read MorePlacental Allograft Reconstruction of Cutaneous Wounds Following Mohs Surgery: A Propensity Score-Matched Comparative Cost-Effectiveness Analysis
May 2025 | Volume 24 | Issue 5 | Original Article | 450 | Copyright © May 2025
Background: The purpose of this study was to examine the cost-effectiveness of placental allograft as a nonoperative surrogate to autologous tissue-based methods of defect r...
Read MoreEfficacy and Tolerability of a Cream in Aging Skin
May 2025 | Volume 24 | Issue 5 | Original Article | 524 | Copyright © May 2025
Background: The clinical presentation of photodamaged and aged skin includes fine lines, wrinkles, and pigmentation changes, which are related to the amount of water in the epide...
Read MoreFULL SUPPLEMENT: Incorporating Cosmeceuticals in In-Office Aesthetic Procedures for Skin of Color
April 2025 | Volume 24 | Issue 4 | Department | 41490s1 | Copyright © April 2025
Common signs of skin aging include wrinkles, fine lines, and pigmentary disorders. Patients with skin of color present with unique dermatologic challenges due to differences in how skin conditions man...
Read More
© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
